Breakthrough: Universal Coronavirus Vaccine Designed By AI Passes Human Trial
In a historic milestone for global public health, an experimental "universal" coronavirus vaccine designed entirely by artificial intelligence (AI) has successfully completed its first human clinical trial. According to peer-reviewed data published in the Journal of Infection, the Phase 1 clinical trial evaluated 39 healthy adult volunteers aged 18 to 50 and demonstrated a 100 per cent safety profile, with…
Key Insights
- This topic is currently trending
- Experts are closely monitoring developments
- It may impact future decisions
